Pawel Zerr

Erlangen, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Composition of TWIST1 dimers regulates fibroblast activation and tissue fibrosis.

Composition of TWIST1 dimers regulates fibroblast activation and tissue fibrosis.

Journal: Annals of the rheumatic diseases

Published: August 25, 2015

Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease.

Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease.

Journal: Rheumatology (Oxford, England)

Published: February 16, 2015

Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis.

Orphan nuclear receptor NR4A1 regulates transforming growth factor-β signaling and fibrosis.

Journal: Nature medicine

Published: July 14, 2014

Tribbles homologue 3 stimulates canonical TGF-β signalling to regulate fibroblast activation and tissue fibrosis.

Tribbles homologue 3 stimulates canonical TGF-β signalling to regulate fibroblast activation and tissue fibrosis.

Journal: Annals of the rheumatic diseases

Published: July 08, 2014

Activating transcription factor 3 regulates canonical TGFβ signalling in systemic sclerosis.

Activating transcription factor 3 regulates canonical TGFβ signalling in systemic sclerosis.

Journal: Annals of the rheumatic diseases

Published: July 04, 2014

Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis.

Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis.

Journal: Annals of the rheumatic diseases

Published: April 14, 2014

Vitamin D receptor regulates TGF-β signalling in systemic sclerosis.

Vitamin D receptor regulates TGF-β signalling in systemic sclerosis.

Journal: Annals of the rheumatic diseases

Published: January 23, 2014

Cardiomyopathy in murine models of systemic sclerosis.

Cardiomyopathy in murine models of systemic sclerosis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: January 15, 2014

S100A4 amplifies TGF-β-induced fibroblast activation in systemic sclerosis.

S100A4 amplifies TGF-β-induced fibroblast activation in systemic sclerosis.

Journal: Annals of the rheumatic diseases

Published: August 26, 2013

Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFβ signalling.

Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFβ signalling.

Journal: Annals of the rheumatic diseases

Published: August 22, 2013

Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages.

Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages.

Journal: Annals of the rheumatic diseases

Published: August 06, 2013

Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosis.

Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosis.

Journal: Annals of the rheumatic diseases

Published: July 09, 2013

Showing 1-12 of 27

Last Updated: 09/26/2026